Novo Nordisk on Wednesday announced its second quarter earnings for 2024.
Novo Nordisk on Wednesday said its net profit came in at 20.05 billion Danish kroner in the second quarter of 2024, below forecasts.
Novo Nordisk on Wednesday posted weaker-than-expected net profit in the second quarter and trimmed its operating profit outlook.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Shares of Wegovy maker Novo Nordisk slide 7% after earnings missNovo Nordisk on Wednesday announced its second quarter earnings for 2024.
Read more »
Wegovy maker Novo Nordisk posts earnings miss, cuts operating profit outlookNovo Nordisk on Wednesday announced its second quarter earnings for 2024.
Read more »
Wegovy maker Novo Nordisk posts earnings miss, cuts operating profit outlookNovo Nordisk on Wednesday announced its second quarter earnings for 2024.
Read more »
Novo Nordisk's Wegovy wins EU backing for reducing heart risksNovo Nordisk's Wegovy has received backing from the EU's medical regulator to expand the weight loss drug's use to reducing the rise of serious heart events.
Read more »
UK Approves Novo Nordisk’s Wegovy As First-Of-Its-Kind Treatment To Lower Heart RisksTy Roush is a New York City-based breaking news reporter who frequently covers Russia’s invasion of Ukraine, the automotive industry and sports money. He joined Forbes in 2022 and has covered Exxon acquiring Pioneer for nearly $60 billion, a mysterious respiratory illness affecting dogs across the U.S.
Read more »
Novo Nordisk's Wegovy weight loss drug wins UK approval for use as a heart treatmentThe U.K.'s health regulator on Tuesday approved the use of Novo Nordisk's Wegovy drug to reduce the risk of obese adults suffering from serious heart problems or strokes.
Read more »